The natural history of untreated severe or critical limb ischemia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Vascular Surgery

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jvs.2015.07.065PMID 26391460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).

  2014cited by this paper
• Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention.

  2013cited by this paper
• Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial.

  2012cited by this paper
• ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases

  2012cited by this paper
• Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: a propensity score analysis.

  2011cited by this paper
• Abstract 8547: Patient-Specific Cellular Therapy (Ixmyelocel-T) is Safe and Improves Time to Treatment Failure in Patients with Critical Limb Ischemia and No Revascularization Options

  2011cited by this paper
• Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia.

  2011cited by this paper
• Autologous Bone-Marrow Mononuclear Cell Implantation Reduces Long-Term Major Amputation Risk in Patients With Critical Limb Ischemia: A Comparison of Atherosclerotic Peripheral Arterial Disease and Buerger Disease

  2011cited by this paper
• Safety of vascular endothelial and hepatocyte growth factor gene therapy in patients with critical limb ischemia.

  2011cited by this paper
• Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.

  2010cited by this paper
• Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.

  2010cited by this paper
• Bypass surgery or percutaneous transluminal angioplasty to treat critical lower limb ischaemia due to infrainguinal arterial occlusive disease?

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Bypass surgery or percutaneous transluminal angioplasty to treat critical lower limb ischaemia due to infrainguinal arterial occlusive disease

  2009cited by this paper
• Peripheral arterial disease--natural outcome.

  2009cited by this paper
• Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

  2008cited by this paper
• Methodology for clinical practice guidelines for the management of arteriovenous access.

  2008cited by this paper
• Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up.

  2008cited by this paper
• Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.

  2008cited by this paper
• Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia

  2008cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.

  2008cited by this paper
• Results of a Double-Blind, Placebo-Controlled Study to Assess the Safety of Intramuscular Injection of Hepatocyte Growth Factor Plasmid to Improve Limb Perfusion in Patients With Critical Limb Ischemia

  2008cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome.

  2007cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization.

  2006cited by this paper
• Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.

  2006cited by this paper
• Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions.

  2003cited by this paper
• Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS).

  2003cited by this paper
• Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.

  2000cited by this paper
• Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group.

  1999cited by this paper
• Spinal Cord Stimulation and Chronic Critical Limb Ischemia

  1999cited by this paper
• Intravenous Hydroxyethylrutosides Combined with Long-Term Oral Anticoagulation in Atherosclerotic Nonreconstructable Critical Leg Ischemia: A Retrospective Study

  1999cited by this paper
• Microcirculatory investigations to determine the effect of spinal cord stimulation for critical leg ischemia: the Dutch multicenter randomized controlled trial.

  1999cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Outcome of unreconstructed chronic critical leg ischaemia.

  1996cited by this paper
• Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study.

  1995cited by this paper
• Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199.

  1993cited by this paper
• Unexpected, late cardiovascular effects of surgery for peripheral artery disease. Veterans Affairs Cooperative Study 199.

  1992cited by this paper
• Second European Consensus Document on chronic critical leg ischemia.

  1991cited by this paper
• The Ischaemic Leg: a Long-Term Follow-Up with Special Reference to the Predictive Value of the Systolic Digital Blood Pressure - Part I: no Arterial Reconstruction

  1989cited by this paper
• The Ischaemic Leg: a Long-Term Follow-Up with Special Reference to the Predictive Value of the Systolic Digital Blood Pressure - Part II: After Arterial Reconstruction

  1989cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

  1934cited by this paper

• Distal bypass may reduce major amputations for chronic limb-threatening ischemia by >50% compared with endovascular therapy alone

  2026cites this paper
• Prognostic impact of Lesion Subset with or without below the Knee Lesion in Chronic Limb-Threatening Ischemia following Endovascular Revascularization.

  2026cites this paper
• Diabetic Peripheral Arterial Disease Versus Thromboangiitis Obliterans: A Multidimensional Comparison of Clinical Phenotype, Biomarkers, and Outcomes.

  2026cites this paper
• Clinical outcomes in patients with chronic limb-threatening ischemia undergoing tibial and pedal bypass with or without preoperative routine coronary angiography.

  2026cites this paper
• Predictors of Mortality in Peripheral Arterial Disease After Endovascular Lower Limb Revascularization and Development of a Risk Score Based Solely on Clinical Presentation.

  2026cites this paper
• We must embrace peripheral artery disease – a trainee perspective

  2026cites this paper
• Evidence for Transcatheter Arterialization of Deep Veins in Poor Option Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-analysis.

  2025cites this paper
• An Office Based Lab (OBL) Can Provide Timely Interventions for Patients with Chronic Limb-Threatening Ischemia

  2025cites this paper
• Akuter Leistenschmerz – differenzialdiagnostisches Vorgehen

  2025cites this paper
• From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review

  2025cites this paper
• Delayed or forgone medical care associated with increased resource utilization and health care expenditures among patients with peripheral artery disease in the United States.

  2025cites this paper
• ICAM1 blockade improves ischemic muscle reperfusion in diabetic mice

  2025cites this paper
• Multidisciplinary Team Approach to Limb Salvage

  2025cites this paper
• Reverse Venous Arterialization Simplified Technique: A Novel Method to Correct an Inadvertently Created Femoral Artery to Peroneal Vein Bypass

  2025cites this paper
• Comparison of Isolated Popliteal Interventions in Chronic Limb Threatening Ischemia.

  2025cites this paper
• Significance of miRNA-128-3p and miRNA-381-3p as Predictors of Patients with Lower Extremity Arterial Sclerosis

  2025cites this paper
• Biopsychosocial Predictors of Long-Term Major Amputation Following Peripheral Vascular Intervention in Chronic Limb-Threatening Ischemia Using a Machine Learning Algorithm Approach

  2025cites this paper
• Evaluation of autologous venous allograft for lower limb in the treatment of critical limb ischemia. The REVATEC (REVAscularisation par greffons veineux bioproTEC) study.

  2025cites this paper
• Conditional Survival Analysis and Risk Factors for Mortality in Patients with Chronic Limb-Threatening Ischemia.

  2025cites this paper
• Effects of low-intensity pulsed ultrasound on clinical parameters in atherosclerotic peripheral artery disease patients with chronic limb-threatening ischemia

  2025cites this paper
• Reproducibility and concordance of Pedal Acceleration Time between students, residents and experts operators: Single-center prospective study.

  2025cites this paper
• The Impact of Postoperative Dual Antiplatelet Therapy on Outcomes of Endovascular Therapies in Patients with Chronic-Limb Threatening Ischemia in the Vascular Quality Initiative-Medicare-Linked Database.

  2025cites this paper
• Efficacy of Direct Injection in Occlusive Lesion (DIOL) Fashion for Infrapopliteal and Inframalleolar Chronic Total Occlusions

  2025cites this paper
• Low-Intensity Pulsed Ultrasound in Patients With Atherosclerotic Peripheral Arterial Disease: A Pilot Study and Randomized Double-Blind Placebo-Controlled Trial

  2025cites this paper
• Enfermedad arterial periférica de miembros inferiores

  2025cites this paper
• A 5-year limb salvage for long-term limb salvage in chronic limb-threatening ischemia without options for revascularization, utilizing a hybrid deep venous arterialization technique: A case report

  2025cites this paper
• Can BlueDop be used as an alternative for diagnosing peripheral arterial disease? A prospective comparison of traditional ABPI and TBPI with BlueDop.

  2025cites this paper
• Comparing the Impact of DOACs and Warfarin on Below-the-Knee Autologous Vein Bypass Patency in Peripheral Artery Disease: A Retrospective Cohort Study with 2-Year Follow-Up

  2025cites this paper
• Therapeutic strategies for critical limb ischemia: a focus on endogenous cell behavior modulation.

  2025cites this paper
• Pre-operative Cilostazol in Patients with Chronic Limb Threatening Ischaemia Associated with Improved Survival after Endovascular Revascularisation.

  2025cites this paper
• Advancing Management of Patients with Lower Extremity Peripheral Artery Disease: A Focused Review and Our Institution's Approach to Post-Endovascular Intervention Care.

  2025cites this paper
• Vein bypass versus endovascular treatment for chronic limb ischaemia

  2025cites this paper
• COMPARATIVE ANALYSIS OF REPEATED REVASCULARIZATION METHODS IN PATIENTS WITH CHRONIC LIMB ISCHEMIA

  2025cites this paper
• Prospective Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus Conventional Balloon Angioplasty in Treating Below the Knee Arterial Lesions in Chronic Limb Threatening Ischemia: The CRURAL DEB Study.

  2025cites this paper
• 3D CT to 2D X-ray image registration for improved visualization of tibial vessels in endovascular procedures

  2025cites this paper
• Imaging practices following peripheral vascular intervention in chronic limb-threatening ischemia and association with amputation outcomes

  2025cites this paper
• Fundamentals of wound care for amputation prevention.

  2025cites this paper
• Facility Medicaid Payer Burden and Nonelective Admission for Chronic Limb-Threatening Ischemia.

  2025cites this paper
• Management of Venous Outflow Branches in Transcatheter Arterialization of Deep Veins.

  2025cites this paper
• Predictors of Perioperative Outcomes in Chronic Limb-threatening Ischemia Patients

  2025cites this paper
• Emerging role of artificial intelligence in the care and management of lower extremity amputations and peripheral nerve injuries

  2025cites this paper
• Cytokine growth factors in the regulation of angiogenesis and atherogenic inflammation in the vascular wall. The role of polysaccharide polymers. Analytical review. Part 1

  2025cites this paper
• Diabetes Status and Long-Term Mortality and Major Amputation Outcomes Following Revascularization in Chronic Limb Threatening Ischemia.

  2025cites this paper
• Comparison of Prognosis in Chronic Limb Threatening after Revascularisation Versus Non-revascularisation Treatment: Analysis of Japanese Regional Insurance Claims.

  2025cites this paper
• Conservative treatment has a role in elderly patients with Chronic Limb-Threatening Ischemia, especially in very elderly patients (≥ 85 years).

  2025cites this paper
• Two-Year Outcomes of Excimer Laser Ablation Combined with Drug-Coated Balloon for Treating De novo Lesions and In-Stent Restenosis in Femoropopliteal Artery of Chronic Limb-Threatening Ischemia Patients.

  2025cites this paper
• Prediction of all-cause mortality in endovascularly treated patients with peripheral arterial disease of the lower extremities.

  2025cites this paper
• Mid-Term Outcomes of Hybrid Revascularisation of Symptomatic Multilevel Peripheral Arterial Disease Across Two Centres.

  2025cites this paper
• Persistent Racial Disparities in Chronic Limb-Threatening Ischemia Outcomes and Utilization Among US Medicare Patients.

  2025cites this paper
• Endovascular Revascularization versus Open Bypass Surgery for Patients with Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2025cites this paper
• mRNA-based in vivo induction of ETV2 to restore blood flow in a preclinical mouse hindlimb ischemia model

  2025cites this paper
• Revascularization in Nonagenarians with Chronic Limb-Threatening Ischemia Can Be Effective

  2025cites this paper
• Oral Anticoagulant Management for Peripheral Vascular Disease.

  2025cites this paper
• Percutaneous mechanical atherothrombectomy versus arterial bypass surgery for femoropopliteal in-stent restenosis: a budget impact analysis

  2025cites this paper
• Hybrid superficial venous arterialization limb salvage for “full metal jacket” peripheral arterial stenting and no-option chronic limb-threatening ischemia: A case report

  2025cites this paper
• Human induced pluripotent stem cell-derived nanovesicles for the treatment of ischemic limb disease.

  2025cites this paper
• Single-vessel versus multiple-vessel endovascular revascularization of infrapopliteal arteries in chronic limb-threatening ischemia patients: a systematic review and meta-analysis.

  2025cites this paper
• Bypass Versus Endovascular Therapy in Chronic Limb Threatening Ischemia Requiring Infra-Popliteal Interventions.

  2025cites this paper
• Dual Antiplatelet Therapy vs. Monotherapy After Surgical Intervention for Chronic Limb-Threatening Ischemia: Systematic Review and Meta-Analysis with Endovascular Subanalysis.

  2025cites this paper
• Angiogenic Ability of Extracellular Vesicles Derived from Angio-miRNA-Modified Mesenchymal Stromal Cells

  2025cites this paper
• International BEST-CLI Collaborative: next steps to create a coordinated global initiative to improve awareness and access while reducing mortality and amputation for patients with chronic limb-threatening ischaemia.

  2025cites this paper
• Transcatheter Arterialization of the Deep Veins for Chronic Limb-Threatening Ischemia: A Case Series of the Direct Cost Associated With Limb Salvage

  2025cites this paper
• Simultaneous percutaneous transmural arterial bypass and deep venous arterialization for treatment of critical limb ischemia

  2025cites this paper
• The difference in mortality rates between endovascular and conservative treatment for patients with chronic limb-threatening ischemia(CLTI):A propensity score matching study.

  2025cites this paper
• The Number of Revascularization Procedures is Associated With Final Amputation Level for Chronic Limb-Threatening Ischemia

  2025cites this paper
• Successful Treatment of Refractory Bilateral Leg Ulcers With an Adsorptive Blood-Purification Device

  2025cites this paper
• Spinal Cord Stimulation for Intractable Chronic Limb Ischemia: A Narrative Review

  2024cites this paper
• Early Tissue Resection Versus Watchful Waiting After Revascularization for Chronic Limb-Threatening Ischemia: A Meta-Analysis

  2024cites this paper
• Outcomes of drug-coated balloon angioplasty in patients with dyslipidemia in the BIOLUX P-III registry: A subgroup analysis

  2024cites this paper
• Association of Undernutrition With Mortality and Amputation Outcomes in Chronic Limb Threatening Ischaemia: A Systematic Review.

  2024cites this paper
• Comparative Study between Rate of Stenting after Mechanical Rotational Thrombectomy Using Rotarex® System versus Balloon Angioplasty for Treatment of Critical Limb Ischemia in the Femoropopliteal Segment

  2024cites this paper
• Recombinant Human Hepatocyte Growth Factor Plasmids for Treating Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-analysis.

  2024cites this paper
• Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review

  2024cites this paper
• 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.

  2024cites this paper
• Retrograde Access for Revascularization of Difficult Peripheral Artery Lesions in Patients with Chronic Limb-threatening Ischemia: A Periprocedural Outcome Analysis of a Single-center Case Series

  2024cites this paper
• Risk Factors for Unplanned Higher-Level Re-Amputation and Mortality after Lower Extremity Amputation in Chronic Limb-Threatening Ischemia

  2024cites this paper
• Percutaneous Deep Venous Arterialization Using an IVUS-Guided Technique in no-Option Patients with Chronic Limb-Threatening Ischemia: 24-Month Results

  2024cites this paper
• The natural history of isolated common femoral endarterectomy for chronic limb-threatening ischemia.

  2024cites this paper
• Hybrid approach to deep vein arterialization as an adjunct for patients with severe medial calcinosis

  2024cites this paper
• Impact of Early Rehabilitation after Endovascular Treatment for Peripheral Arterial Disease

  2024cites this paper
• Using administrative data to better treat chronic limb threatening ischemia.

  2024cites this paper
• Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events

  2024cites this paper
• Magnetic Resonance Imaging and Histological Insights Into Deep Venous Arterialisation

  2024cites this paper
• The treatment effect of endovascular therapy for chronic limb‐threatening ischemia with systemic sclerosis

  2024cites this paper
• HYBRID VASCULAR APPROACH REDUCES THE INTENSIVE CARE UNIT STAY IN PATIENTS WITH CHRONICALLY THREATENING LIMB ISCHEMIA AND MULTILEVEL ATHEROSCLEROTIC LESIONS

  2024cites this paper
• Common Criticisms and Rebuttals of The BEST-CLI Trial.

  2024cites this paper
• Comparison of Mortality and Amputation after Lower Extremity Bypass vs. Peripheral Vascular Intervention in Patients with Chronic Limb-Threatening Ischemia and Comorbid Chronic Kidney Disease.

  2024cites this paper
• Medical Optimization of Patients with Symptomatic Peripheral Arterial Disease.

  2024cites this paper
• 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2024cites this paper
• 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2024cites this paper
• Appropriate care in chronic limb threatening ischemia: A review of current evidence and outcomes.

  2024cites this paper
• Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.

  2024cites this paper
• Safety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study

  2024cites this paper
• Intravascular lithotripsy-assisted percutaneous deep vein arterialization for no-option chronic limb-threatening patients and heavily calcified tibial occlusive disease

  2024cites this paper
• Emerging trends in nationwide mortality, limb loss, and resource utilization for critical limb ischemia in young adults.

  2024cites this paper
• Health Literacy and Disease Knowledge of Patients With Peripheral Arterial Disease or Abdominal Aortic Aneurysm: A Scoping Review.

  2024cites this paper
• Narrative Review of Biological Markers in Chronic Limb-Threatening Ischemia

  2024cites this paper
• Health-Related Quality of Life Instruments in Chronic Limb-Threatening Ischemia: Evolution of Defining Quality of Life in a Complex Disease State.

  2024cites this paper
• Distal Adjuncts for High Risk Lower Extremity Bypasses.

  2024cites this paper
• LONG-TERM RESULTS OF RECONSTRUCTIVE AND RECOVERY OPERATIONS ABOUT CHRONIC CRITICAL ISCHEMIA OF THE LOWER EXTREMITIES

  2024cites this paper